Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer? Hasitha ManoharAdam S. PotterNicolas L. Palaskas Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors) 28 May 2022 Pages: 599 - 606
COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave Ahmed A. KolkailahKayla RiggsAmit Khera Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors) 01 July 2022 Pages: 607 - 617
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know Johnathon Seth ParhamAnne Carol Goldberg Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors) 06 June 2022 Pages: 619 - 625
SGLT-2 Inhibitors for Patients with Heart Failure: What Have We Learned Recently? Mahmoud Al RifaiL. Kristin NewbySalim S. Virani Coronary Heart Disease (S. Virani and M. Al Rifai, Section Editors) 02 June 2022 Pages: 627 - 634
LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated? Lamija FerhatbegovićDenis MršićBelma Pojskić Statin Drugs (R. Ceska, Section Editor) 28 May 2022 Pages: 635 - 642
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management Mohamad B. TahaTamer YahyaKhurram Nasir Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 28 May 2022 Pages: 643 - 654
Bioactives in the Food Supply: Effects on CVD Health Sisi CaoConnie M. Weaver Nutrition (K. Petersen, Section Editor) 28 May 2022 Pages: 655 - 661
Statins in Pregnancy: Can We Justify Early Treatment of Reproductive Aged Women? Amelie PhamAleksandra PolicJennifer L. Thompson Children/Adolescents/Young Adults and Atherosclerosis (D.P. Wilson, Section Editor) 14 June 2022 Pages: 663 - 670
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions Melody HermelStacy TsaiSalim S. Virani Reviews and Scientific Meetings and New Research Implications (S. Virani, Section Editor) 28 May 2022 Pages: 671 - 680